Alteration of the nasal responses to influenza virus by tobacco smoke

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 1, 2012, Pages 24-31

  Noah, Terry L ^a   Zhou, Haibo ^a,b   Jaspers, Ilona ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

Influenza; Interferon; Tobacco smoke

Indexed keywords

CYTOKINE; TOBACCO SMOKE;

ANTIOXIDANT ACTIVITY; CHRONICITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NONHUMAN; NOSE MUCOSA; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SMOKING; VIRUS ATTENUATION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; SMOKING; VIRUS REPLICATION;

EID: 84857036826     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32834ecc80     Document Type: Review

References (43)

1. Swerdlow DL, Finelli L, Bridges CB. 2009 H1N1 influenza pandemic: field and epidemiologic investigations in the United States at the start of the first pandemic of the 21st century. Clin Infect Dis 2011; 52 (Suppl 1):S1-S3.
2. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164:2206-2216. (Pubitemid 39452980)
3. Kark JD, Lebiush M. Smoking and epidemic influenza-like illness in female military recruits: a brief survey. Am J Public Health 1981; 71:530-532. (Pubitemid 11156476)
4. Rogot E, Murray JL. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 1980; 95:213-222. (Pubitemid 10061912)
5. Kark JD, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N Engl J Med 1982; 307:1042-1046. (Pubitemid 12027060)
6. Lebiush M, Rannon L, Kark JD. An outbreak of A/USSR/90/77 (H1N1) influenza in army recruits: clinical and laboratory observations. Mil Med 1982; 147:43-48. (Pubitemid 12139299)
7. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009; 4:e6051.
8. Robbins CS, Bauer CM, Vujicic N, et al. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 2006; 174:1342-1351. (Pubitemid 44913036)
9. Gaschler GJ, Zavitz CC, Bauer CM, et al. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Respir Cell Mol Biol 2008; 38:218-226. Mice exposed for 8 weeks to cigarette smoke had attenuated alveolar macrophage cytokine production after stimulation with poly I:C, a viral mimic. This effect was reversible when smoke exposure was stopped. (Pubitemid 351162844)
10. Feng Y, Kong Y, Barnes PF, Huang FF, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and mycobacterium tuberculosis. Infect Immun 2011; 79:229-237. Exposure of mice to second-hand cigarette smoke for 4 h per day, 5 days per week, for 6 weeks resulted in reduced lung T-cell IFNg production, increased weight loss, and increased mortality after influenza A infection. Increased susceptibility to Mycobacterium tuberculosis infection was also observed.
11. Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus in cigarette-exposed mice. J Virol 2011; 85:4679-4690. Cigarette smoke-exposed (10 cigarettes per day for 4 days) Nrf2-deficient mice showed higher rates of mortality than wild-type mice after influenza virus infection, with enhanced peribronchial inflammation, lung permeability damage, lung oxidant levels, and mucus hypersecretion.
12. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809. (Pubitemid 32979631)
13. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6:135.
14. Ciencewicki J, Gowdy K, Krantz QT, et al. Diesel exhaust enhanced susceptibility to influenza infection is associated with decreased surfactant protein expression. Inhal Toxicol 2007; 19:1121-1133. (Pubitemid 350072471)
15. Jaspers I, Ciencewicki JM, Zhang W, et al. Diesel exhaust enhances influenza virus infections in respiratory epithelial cells. Toxicol Sci 2005; 85:990-1002. (Pubitemid 40846874)
16. Jaspers I, Horvath KM, Zhang W, et al. Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza. Am J Respir Cell Mol Biol 2010; 43:368-375. Nasal epithelial cells in long-term, differentiated (air-liquid interface) culture from smokers had reduction in influenza A-induced type I interferon pathway mediators, including the transcription factor IRF7, IFNa, and IFNb compared with cultures from nonsmokers. Analogous results were observed when freshly biopsied nasal epithelium from smokers and nonsmokers were compared after nasal inolcuation with LAIV.
17. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006; 7:132.
18. Pace E, Ferraro M, Siena L, et al. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology 2008; 124:401-411. (Pubitemid 351793472)
19. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res 2008; 57:497-503.
20. Mortaz E, Lazar Z, Koenderman L, et al. Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respir Res 2009; 10:47.
21. Lambert C, Li J, Jonscher K, et al. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J Biol Chem 2007; 282:19666-19675. (Pubitemid 47100056)
22. Cho H-Y, Imani F,Miller-Degraff L, Walters D, et al. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus (RSV) disease. Am J Resp Crit Care Med 2009; 179:138-150. Compared with wild-type mice, significantly attenuated viral clearance and IFN-g, body weight loss, heightened protein/lipid oxidation, and AP-1/NF-kB activity along with suppressed antioxidant induction was found in Nrf2(-/-) mice in response to RSV. Sulforaphane pretreatment significantly limited lung RSV replication and virus-induced inflammation in Nrf2(+/+) but not in Nrf2(-/-) mice. This study showed that manipulation of antioxidant pathways can have a significant impact on the course of RSV, like influenza another clinically important human RNA virus.
23. Kulkarni R, Rampersaud R, Aguilar JL, et al. Cigarette smoke inhibits airway epithelial innate immune responses to bacteria. Infect Immun 2010; 78:2146-2152.
24. Li Q, Tang L, Roberts PC, et al. Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts. Mol Cancer Res 2008; 6:770-784.
25. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89:1-47.
26. Kang MJ, Lee CG, Lee JY, et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008; 118:2771-2784.
27. Castro SM, Kolli D, Guerrero-Plata A, et al. Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation. Toxicol Sci 2008; 106:509-518.
28. Horvath KM, Brighton LE, Zhang W, et al. Epithelial cells from smokers modify dendritic cell responses in the context of influenza infection. Am J Respir Cell Mol Biol 2011; 45:237-245.
29. Wu W, Patel KB, Booth JL, et al. Cigarette smoke extract suppresses the RIG-I-initiated innate immune response to influenza virus in the human lung. Am J Resp Physiol Lung Cell Mol Physiol 2011; 300:L821-L830. Explanted human lung tissue (from patients undergoing resection for cancer), exposed ex vivo to cigarette smoke extract at noncytotoxic concentrations, had suppression of influenza A-induced expression of IP-10, IFNb, and RIG-I.
30. Kesic MJ, Simmons O, Bauer R, Jaspers I. Nrf2 expression modifies influenza virus entry and replication in epithelial cells. Free Radic Biol Med 2011; 51:444-453.
31. Boyce TG, Gruber WC, Coleman-Dockery SD, et al. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999; 18:82-88. (Pubitemid 29432141)
32. Maassab HF, Bryant ML. The development of live attenuated coldadapted influenza virus vaccine for humans. Rev Med Virol 1999; 9:237-244.
33. Zangwill KM. Cold-adapted, live attenuated intranasal influenza virus vaccine. Pediatr Infect Dis J 2003; 22:273-274. (Pubitemid 36351077)
34. Hammitt LL, Bartlett JP, Li S, Rahkola J, et al. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine 2009; 27:7359-7366.
35. Noah TL, Zhou H, Monaco J, et al. Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus. Environ Health Perspect 2011; 119:78-83. Healthy young adult smokers had decreased levels of IL-6 and increased virus sequence quantity in nasal secretions after inoculation with standard vaccine dose of LAIV, compared with nonsmokers. Nonsmokers routinely exposed to second-hand smoke had intermediate responses.
36. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005; 175:3463-3468. (Pubitemid 41292002)
37. + T cells. PLoS Pathog 2008; 4:e1000006. doi: 10.1371/journal.ppat.1000006. (Pubitemid 351340691)
38. Horvath KM, Herbst M, Zhou H, et al. Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus. Respir Res 2011; 12:102. doi: 1186/1465-9921-12-102. NK cells were identified as a prominent immune cell type in nasal secretions, and activation of 'cytotoxic' phenotype NK cells after LAIV inolcuation was suppressed in smokers compared with nonsmokers.
39. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002; 71:173-183.
40. Walzer T, Dalod M, Vivier E, Zitvogel L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther 2005; 5 (Suppl 1):S49-S59. (Pubitemid 41243345)
41. Munz C. Noncytotoxic protection by human NK cells in mucosal secondary lymphoid tissues. Eur J Immunol 2008; 38:2946-2948.
42. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640. (Pubitemid 33043908)
43. van Zyl-Smit RN, Brunet L, Pai M, Yew WW. The convergence of global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am 2010; 24:693-703.